FindTrial
Sign In

A prospective, two-way cohort study evaluating the progress of a multicenter clinical study of circulating tumor cell detection and routine testing to assist in the diagnosis and treatment of neuroblastoma

A prospective, two-way cohort study evaluating the progress of a multicenter clinical study of circulating tumor cell detection and routine testing to assist in the diagnosis and treatment of neuroblastoma

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500096400
Enrollment
Unknown
Registered
2025-01-23
Start date
2025-02-01
Completion date
Unknown
Last updated
2025-03-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neuroblastoma

Interventions

Queue 1:None
Queue 2:None

Sponsors

Shenzhen Children’s Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 18 Years

Inclusion criteria

Inclusion criteria: 1.0-18 years old; 2.Voluntarily sign the informed consent form; 3.Confirmed diagnosis of neuroblastoma by pathological cytology or histology; 4.No history of other malignant tumors;

Exclusion criteria

Exclusion criteria: 1.Over 18 years old; 2.Refusal to sign informed consent; 3.Concurrent participation in another interventional clinical study;

Design outcomes

Primary

MeasureTime frame
3y-rwEFS3-year real-world event-free survival rate;—

Secondary

MeasureTime frame
2-year Real World Event Free Survival Rate;1-year event free survival rate in the real world;—

Countries

China

Contacts

Public ContactYuan Xiuli

Shenzhen Children’s Hospital

18938690212@163.com+86 18938690212

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026